137 related articles for article (PubMed ID: 19088475)
1. Wound healing is not impaired in rats undergoing perioperative treatment with the antineoplastic agent taurolidine.
Braumann C; Guenther N; Pohlenz J; Pfirrmann RW; Menenakos C
Eur Surg Res; 2009; 42(2):91-6. PubMed ID: 19088475
[TBL] [Abstract][Full Text] [Related]
2. Effects of topical application of taurolidine on second intention healing of experimentally induced wounds in rats.
Simpson JM; Séguin B; Gitelman AI
Am J Vet Res; 2008 Sep; 69(9):1210-6. PubMed ID: 18764696
[TBL] [Abstract][Full Text] [Related]
3. Leukopoiesis is not affected after intravenous treatment with the novel antineoplastic agent taurolidine. Results of an experimental study in rats.
Braumann C; Menenakos C; Atanassov V; Pfirrmann RW; Guenther N; Jacobi CA
Eur Surg Res; 2008; 40(4):341-6. PubMed ID: 18303270
[TBL] [Abstract][Full Text] [Related]
4. The tumor suppressive reagent taurolidine inhibits growth of malignant melanoma--a mouse model.
Braumann C; Jacobi CA; Rogalla S; Menenakos C; Fuehrer K; Trefzer U; Hofmann M
J Surg Res; 2007 Dec; 143(2):372-8. PubMed ID: 17612567
[TBL] [Abstract][Full Text] [Related]
5. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
Da Costa ML; Redmond HP; Bouchier-Hayes DJ
J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
[TBL] [Abstract][Full Text] [Related]
6. Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.
Bobrich E; Braumann C; Opitz I; Menenakos C; Kristiansen G; Jacobi CA
J Surg Res; 2007 Jan; 137(1):75-82. PubMed ID: 17109891
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of normal saline and taurolidine on intra-abdominal adhesion formation and peritoneal fibrinolysis.
Tarhan OR; Barut I; Sezik M
J Surg Res; 2008 Jan; 144(1):151-7. PubMed ID: 17981298
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer.
Darnowski JW; Goulette FA; Cousens LP; Chatterjee D; Calabresi P
Cancer Chemother Pharmacol; 2004 Sep; 54(3):249-58. PubMed ID: 15173956
[TBL] [Abstract][Full Text] [Related]
9. High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats.
Braumann C; Stuhldreier B; Bobrich E; Menenakos C; Rogalla S; Jacobi CA
J Surg Res; 2005 Nov; 129(1):129-35. PubMed ID: 15916768
[TBL] [Abstract][Full Text] [Related]
10. Divergent effects of taurolidine as potential anti-neoplastic agent: inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivo.
Abramjuk C; Bueschges M; Schnorr J; Jung K; Staack A; Lein M
Oncol Rep; 2009 Aug; 22(2):409-14. PubMed ID: 19578784
[TBL] [Abstract][Full Text] [Related]
11. Taurolidine in the prevention and therapy of lung metastases.
Hoksch B; Rufer B; Gazdhar A; Bilici M; Beshay M; Gugger M; Schmid RA
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1058-63. PubMed ID: 19850492
[TBL] [Abstract][Full Text] [Related]
12. Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy.
Braumann C; Ordemann J; Kilian M; Wenger FA; Jacobi CA
Clin Exp Metastasis; 2003; 20(5):387-94. PubMed ID: 14524527
[TBL] [Abstract][Full Text] [Related]
13. Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats.
Braumann C; Schoenbeck M; Menenakos C; Kilian M; Jacobi CA
Clin Exp Metastasis; 2005; 22(1):77-83. PubMed ID: 16132581
[TBL] [Abstract][Full Text] [Related]
14. The effect of taurolidine on brain tumor cells.
Stendel R; Stoltenburg-Didinger G; Al Keikh CL; Wattrodt M; Brock M
Anticancer Res; 2002; 22(2A):809-14. PubMed ID: 12014655
[TBL] [Abstract][Full Text] [Related]
15. Perioperative immune modulation.
Little D; Regan M; Keane RM; Bouchier-Hayes D
Surgery; 1993 Jul; 114(1):87-91. PubMed ID: 8356532
[TBL] [Abstract][Full Text] [Related]
16. Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model.
Opitz I; Van der Veen H; Witte N; Braumann C; Mueller JM; Jacobi CA
Eur Surg Res; 2007; 39(3):129-35. PubMed ID: 17337889
[TBL] [Abstract][Full Text] [Related]
17. The effect of taurolidine on experimental thrombus formation.
Kaptanoglu L; Kucuk HF; Colak E; Kurt N; Bingul SM; Akyol H; Torlak OA; Yazici F
Eur J Pharmacol; 2008 Jan; 578(2-3):238-41. PubMed ID: 17961549
[TBL] [Abstract][Full Text] [Related]
18. Effect of rapamycin on wound healing: an experimental study.
Ekici Y; Emiroglu R; Ozdemir H; Aldemir D; Karakayali H; Haberal M
Transplant Proc; 2007 May; 39(4):1201-3. PubMed ID: 17524932
[TBL] [Abstract][Full Text] [Related]
19. Effect of carnitine on cutaneous wound healing in immunosuppressed rats.
Akkus A; Aydinuraz K; Daphan C; Saygun O; Caglayan O; Edremitlioglu M; Agalar F
J Surg Res; 2009 Aug; 155(2):301-5. PubMed ID: 19505698
[TBL] [Abstract][Full Text] [Related]
20. Influence of leukotriene inhibitor montelukast on wound contraction and cutaneous healing process in rats.
Tolazzi AR; Tolazzi KD; Garcia M; Graf RM; Freitas RS; Baretta GA; Matias JE; Campos AC
Aesthetic Plast Surg; 2009 Jan; 33(1):84-9. PubMed ID: 18797959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
